Spirulina
Also known as: Arthrospira, blue‑green algae
Systematic reviews and meta‑analyses of randomized trials report small reductions in body weight and waist circumference with spirulina supplementation versus control. Network meta‑analyses also place spirulina among nutraceuticals associated with modest improvements in weight and lipid/glycaemic endpoints, while preclinical reviews describe antioxidant and antitoxic effects.
Last reviewed: 2026-10-14 · 4 indexed studies
Set your location for accurate regulatory status
Saved on this device — no sign-in needed.
Overview
Spirulina (Arthrospira) is a blue‑green microalga used as a dietary supplement with antioxidant and nutrient content. Human trial syntheses report small favourable effects on body weight and some metabolic parameters, while preclinical data suggest broader antitoxic and antioxidant actions.
Mechanism & Function
Mechanism of Action
Proposed mechanisms from the literature include antioxidant and anti‑inflammatory actions (attributed in part to phycocyanin and other bioactive pigments), modulation of lipid and glucose metabolism, and nutrient‑related effects; the exact mechanisms in humans remain incompletely characterised in the provided abstracts.
Physiological Role
Source of protein, pigments and micronutrients; potential antioxidant and metabolic modulatory effects in humans as suggested by clinical trial syntheses.
Primary Pathways
Performance / Health Relevance
Not a classical ergogenic ingredient. Relevant to general health and metabolic endpoints such as modest weight reduction and improvements in lipid or glycaemic markers reported in aggregated clinical trials.
Evidence Review
Practical Use & Dosage
- Minimum Effective Dose
- Not established from the provided abstracts
- Optimal Range
- Not established from the provided abstracts
- Upper / Caution Level
- Not established from the provided abstracts
- Timing
- Varied across trials; not specified in provided abstracts
- Best Format
- Powder or tablet formulations are commonly used in trials (specific format not detailed in provided abstracts)
- Bioavailability
- Not detailed in the provided abstracts
- Absorption Considerations
- Not detailed in the provided abstracts
Safety & Interactions
Side Effects
- •Not reported in the provided abstracts; clinical trial syntheses did not highlight major adverse effects
Contraindications
- Not specified in the provided abstracts
Drug Interactions
- •Not specified in the provided abstracts
Who Should Avoid
- •Not specified in the provided abstracts
Monitoring
Clinical trial syntheses summarised efficacy and did not report systematic safety concerns in the provided abstracts; monitor standard clinical parameters if used for metabolic indications
Frequently Asked Questions
Auto-generated from indexed evidence — dosage, safety, interactions, and more.
When is Spirulina typically used or indicated?
Spirulina is most commonly used for: General nutritional supplement, Support for weight management, Support for lipid and glycaemic measures, Adjunct in plant‑based dietary approaches. Source of protein, pigments and micronutrients; potential antioxidant and metabolic modulatory effects in humans as suggested by clinical trial syntheses.
How does Spirulina work?
Proposed mechanisms from the literature include antioxidant and anti‑inflammatory actions (attributed in part to phycocyanin and other bioactive pigments), modulation of lipid and glucose metabolism, and nutrient‑related effects; the exact mechanisms in humans remain incompletely characterised in the provided abstracts.
What is the recommended dose of Spirulina?
The optimal range is Not established from the provided abstracts. with a minimum effective dose of Not established from the provided abstracts. Best taken: Varied across trials; not specified in provided abstracts. Upper / caution level: Not established from the provided abstracts.
What are the side effects of Spirulina?
Reported side effects include: Not reported in the provided abstracts; clinical trial syntheses did not highlight major adverse effects. Monitoring: Clinical trial syntheses summarised efficacy and did not report systematic safety concerns in the provided abstracts; monitor standard clinical parameters if used for metabolic indications
Does Spirulina interact with medications?
Known or theoretical interactions: Not specified in the provided abstracts. Always check with a clinician before combining with prescription medication.
Who should avoid Spirulina?
Spirulina is generally not recommended for: Not specified in the provided abstracts; and Not specified in the provided abstracts.
How strong is the evidence for Spirulina?
Evidence level: Moderate (overall score 63/100), based on 4 indexed studies on SuppIndex.
Research & References (4)
Comparative effects of nutraceuticals on body weight in adults with overweight or obesity: A systematic review and network meta-analysis of 111 randomized clinical trials.
Network meta‑analysis of 111 randomized trials of nutraceuticals for weight loss in adults with overweight/obesity through November 2022.
A network meta-analysis on the comparative effect of nutraceuticals on lipid profile in adults.
Network meta‑analysis comparing multiple nutraceuticals for effects on LDL‑C and other lipid measures up to February 2021.
Spirulina supplementation and anthropometric indices: A systematic review and meta-analysis of controlled clinical trials.
Systematic review and meta‑analysis of controlled clinical trials up to November 2019 assessing spirulina and anthropometric indices.
Systematic Review of the Effects of Plant-Based Foods on Metabolic Outcomes in Adults with MASLD and Comorbidities Such as Obesity, Metabolic Syndrome, and Type 2 Diabetes.
Systematic review (2020–2025) of plant‑based foods in adults with MASLD and comorbidities; spirulina included among interventions studied.
Related Ingredients
Other top-rated ingredients in General Health Ingredients.
Piperine
82/100A piperidine alkaloid (C₁₇H₁₉NO₃) that inhibits cytochrome P450 enzymes (CYP3A4, CYP1A2, CYP2E1), P-glycoprotein efflux transporters, and UDP-glucuronosyltransferases while enhancing intestinal permeability, digestive enzyme secretion, and splanchnic blood flow — collectively producing dramatic improvements in nutrient bioavailability.
CoQ10
78/100Endogenous lipid-soluble ubiquinone/ubiquinol that shuttles electrons in the mitochondrial respiratory chain and acts as a membrane antioxidant.
Beta-Glucan (Oat)
77/100Multiple randomized trials and meta-analyses report that ≥3 g/day oat beta-glucan lowers LDL and total cholesterol modestly. Acute feeding trials pooled in meta-analysis show dose- and molecular-weight–dependent reductions in postprandial glucose and insulin responses.
Research Overview
Moderate EvidenceCite this ingredient
One-click citation export in APA, MLA, Chicago, BibTeX, or HTML. The URL below is stable and safe to link.
Stable URL
https://thesuppindex.com/ingredients/spirulina
SuppIndex. (2026). Spirulina: Evidence summary, dosage and clinical studies. Retrieved October 16, 2026, from https://thesuppindex.com/ingredients/spirulina
Based on 4 indexed studies · Evidence level: Moderate.
Goal Ratings
Stack Compatibility
Often studied alongside dietary interventions; interaction data with specific pharmaceuticals not detailed in the provided abstracts
